Travers Smith has advised long-standing client Volex plc ("Volex"), a critical manufacturing partner to category leaders, delivering complex power and data connectivity solutions, on the acquisition of the remaining 64.3% of the issued share capital of Kepler SignalTek Ltd ("KST"), taking Volex's ownership of KST to 100%.
KST is a specialist manufacturer of patient-connected medical products, including single-use and reusable cables and devices used in patient monitoring, surgical procedures, cardiac therapy and ultrasound imaging, and Volex has been an investor in KST since its formation in 2017.
The Travers Smith team on this transaction was led by our Corporate Partner Tom Coulter and Senior Consultant Spencer Summerfield, with support from Senior Counsel Joe Knox, and Associates Marie Morazzani and Sylvia Mueller. Specialist advice was provided by our Head of Tax Hannah Manning, Senior Counsel Joseph Sheldrick, Associate Amy Broderick, and by our Head of Operational Risk & Environment John Buttanshaw and Senior Associate Harrie Narain.
The acquisition, for a total consideration of up to $89.4m, strengthens Volex's existing Medical business, which focuses on complex cable assemblies carrying power and data within medical equipment such as MRI scanners, robotic surgery devices, and diagnostic imaging systems, by extending Volex into patient-connected products used directly in clinical applications.
